Table 2.
Outcome | 5 Years |
10 Years |
P-value | ||
---|---|---|---|---|---|
TAE | TME | TAE | TME | ||
Overall survival (%) | 95 | 97 | 91 | 90 | 0.910 |
Without risk factor | 97 | 100 | 96 | 94 | 0.680 |
With risk factor | 94 | 96 | 90 | 88 | 0.890 |
Cancer-specific survival (%) | 98 | 100 | 98 | 100 | 0.220 |
Without risk factor | 100 | 100 | 100 | 100 | 0.220 |
With risk factor | 97 | 99 | 97 | 99 | 0.320 |
Recurrence-free survival (%) | 90 | 99 | 86 | 99 | <0.001 |
Without risk factor | 96 | 100 | 93 | 100 | 0.038 |
With risk factor | 84 | 98 | 80 | 97 | 0.001 |
Local recurrence rate (%) | 10 | 0 | 10 | 0 | <0.001 |
Without risk factor | 4 | 0 | 4 | 0 | 0.140 |
With risk factor | 16 | 1 | 16 | 1 | <0.001 |
TAE, transanal excision; TME, total mesorectal excision.
Risk factors included deep submucosal invasion, lymphovascular invasion, and poor histology results.